4//SEC Filing
Long David W 4
Accession 0001387131-19-008131
CIK 0001528557other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:50 PM ET
Size
18.4 KB
Accession
0001387131-19-008131
Insider Transaction Report
Form 4
Long David W
CFO/Sr. VP/Sec./Treas.
Transactions
- Disposition to Issuer
Non-qualified stock option (right to buy)
2019-10-29$3.73/sh−590,048$2,200,879→ 0 totalExercise: $0.55Exp: 2021-09-04→ Common Stock (590,048 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2019-10-29$3.11/sh−100,000$311,000→ 0 totalExercise: $1.17Exp: 2027-04-06→ Common Stock (100,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2019-10-29$2.82/sh−100,000$282,000→ 0 totalExercise: $1.46Exp: 2026-06-22→ Common Stock (100,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2019-10-29$3.08/sh−110,000$338,800→ 0 totalExercise: $1.20Exp: 2029-01-31→ Common Stock (110,000 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2019-10-29$3.53/sh−285,773$1,008,579→ 0 totalExercise: $0.75Exp: 2024-06-04→ Common Stock (285,773 underlying) - Disposition to Issuer
Non-qualified stock option (right to buy)
2019-10-29$3.23/sh−110,000$355,300→ 0 totalExercise: $1.05Exp: 2028-02-01→ Common Stock (110,000 underlying)
Footnotes (8)
- [F1]On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
- [F2]This option provided for vesting over a period of four years, with the first 25% vesting on September 5, 2012 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
- [F3]At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes.
- [F4]This option provided for vesting over a period of four years, with the first 25% vesting on June 5, 2015 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
- [F5]This option provided for vesting over a period of four years, with the first 25% vesting on June 23, 2017 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
- [F6]This option provided for vesting over a period of four years, with the first 25% vesting on April 7, 2018 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
- [F7]This option provided for vesting over a period of four years, with the first 25% vesting on February 2, 2019 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
- [F8]This option provided for vesting over a period of four years, with the first 25% vesting on February 1, 2020 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
Documents
Issuer
Corindus Vascular Robotics, Inc.
CIK 0001528557
Entity typeother
Related Parties
1- filerCIK 0001642614
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:50 PM ET
- Size
- 18.4 KB